online consultation
Online Prescription for Wegovy® to Support Weight Management
instantMD offers Wegovy® consultations to support your weight loss journey. Our board-certified doctors assess eligibility for this FDA-approved medication, crucial for individuals aiming to achieve a healthier BMI. In cases of Wegovy® shortages, compounded semaglutide may be recommended as an alternative.*
Wegovy® is a groundbreaking weight management solution, offering potential benefits like increased energy and reduced risk of chronic diseases such as cardiovascular conditions. Eligible individuals must have a BMI of 30 kg/m² or higher, or a BMI of 27 kg/m² or higher with weight-related health issues.
Receive expert guidance on Wegovy® through our monthly telehealth appointments, ensuring personalized medical supervision. Wegovy® is self-administered through subcutaneous injections, available in doses from 0.25 mg to 2.4 mg, alongside lifestyle modifications.
FDA-approved for weight loss, Wegovy® complements a reduced-calorie diet and increased physical activity, aiding in reducing heart disease risk, improving energy levels, and managing blood sugar, cholesterol, and blood pressure levels.
instantMD offers alternatives like compounded semaglutide and Zepbound® for those seeking different weight management solutions. We prioritize personalized care while ensuring adherence to regulatory standards and guidelines.
How instantMD Helps You Lose Weight
Start Losing Weight in 3 Easy Steps
Choose plan
Pricing plan
Prescription Consultation for FDA-Approved Medications
$129
Insurance Reimbursement: If you have insurance, you can submit your visit with the super bill we provide. This allows you to claim eligible expenses from your insurance provider.
faqs
Wegovy® Prescription FAQs
instantMD's online doctors assess eligibility for Wegovy® based on BMI and weight-related conditions like type 2 diabetes or hypertension. A comprehensive evaluation includes a review of medical history, medications, and necessary tests.
Wegovy® price ranges from $1300-1500 at pharmacies. Insurance coverage varies, often requiring prior authorization. Medicare typically doesn't cover obesity medications. instantMD assists with prior authorization, and uninsured individuals can purchase at full price.
Yes, Wegovy® users experience an average 15% body weight loss over about one year, when combined with a reduced-calorie diet and increased physical activity.
Clinical trials show an average weight loss of 15% body weight, about 33 pounds, over 68 weeks. Sustainable results are achieved with lifestyle modifications.
Wegovy® is approved for long-term weight management. Your doctor will develop a maintenance plan after achieving weight goals.
Wegovy® enhances GLP-1 hormone activity, improving blood sugar uptake, reducing cravings, and promoting satiety with less food, aiding adherence to a lower-calorie diet.
Both contain semaglutide, but Wegovy® is for overweight individuals with related health issues, while Ozempic® targets type 2 diabetes management. Wegovy® has higher doses, up to 2.4 mg, compared to Ozempic®'s range of 0.25 mg to 2 mg.